Three bovine veterinarians had undetected H5N1 avian influenza infections despite no apparent contact with infected cows, suggesting that there may be U.S. states with unidentified positive cases of ...

Investing.com -- Morgan Stanley expects the FDA to approve Gilead Sciences (NASDAQ: GILD )' Lenacapavir (LEN) for HIV ...

Ligand originated, structured, and invested $50 million and led a syndicate of co-investors who invested $25 million in ...

Salesforce is expected to report fourth-quarter results after the market closes Wednesday, with analysts largely bullish on the cloud-based software company's stock, anticipating AI-driven gains.

The pharma industry is delivering game-changing therapies with favorable regulatory support. Amid this backdrop, investors ...

The discussion ended with a bold call to action for businesses, healthcare providers, and policymakers: health equity must be a priority—not just ethically, but economically. As Burgess put it: “This ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

The EMA is set to perform accelerated reviews of Gilead Sciences’ applications for its twice-yearly injectable for HIV ...

Gilead (GILD) announced that the European Medicines Agency has validated for parallel accelerated review the company’s marketing authorization ...

A common CV risk factor calculator for patients with HIV underestimates risk for Black patients and women, while risk for ...

We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...